These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 27059672)
21. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells. Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379 [TBL] [Abstract][Full Text] [Related]
22. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production. Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701 [TBL] [Abstract][Full Text] [Related]
23. Hair follicle structures targeted by antibodies in patients with alopecia areata. Tobin DJ; Hann SK; Song MS; Bystryn JC Arch Dermatol; 1997 Jan; 133(1):57-61. PubMed ID: 9006373 [TBL] [Abstract][Full Text] [Related]
24. Vasoactive intestinal peptide and its receptors in human ovarian cortical follicles. Gabbay-Benziv R; Ao A; Fisch B; Zhang L; Oron G; Kessler-Icekson G; Ben-Haroush A; Krissi H; Abir R PLoS One; 2012; 7(5):e37015. PubMed ID: 22623971 [TBL] [Abstract][Full Text] [Related]
25. Dandruff lesional scalp skin exhibits epidermal T cell infiltration and a weakened hair follicle immune privilege. Limbu SL; Purba TS; Harries M; Kundu R; Bhogal RK; Paus R Int J Cosmet Sci; 2024 Oct; 46(5):717-733. PubMed ID: 38488328 [TBL] [Abstract][Full Text] [Related]
26. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts. Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383 [TBL] [Abstract][Full Text] [Related]
27. Does dysfunctional autophagy contribute to immune privilege collapse and alopecia areata pathogenesis? Hardman JA; Nicu C; Tai C; Harries M; Mironov A; Purba TS; Paus R J Dermatol Sci; 2020 Oct; 100(1):75-78. PubMed ID: 32900572 [No Abstract] [Full Text] [Related]
28. Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle. Uchida Y; Gherardini J; Pappelbaum K; Chéret J; Schulte-Mecklenbeck A; Gross CC; Strbo N; Gilhar A; Rossi A; Funk W; Kanekura T; Almeida L; Bertolini M; Paus R J Autoimmun; 2021 Nov; 124():102711. PubMed ID: 34479087 [TBL] [Abstract][Full Text] [Related]
29. Hair follicle is a target of stress hormone and autoimmune reactions. Ito T J Dermatol Sci; 2010 Nov; 60(2):67-73. PubMed ID: 20943348 [TBL] [Abstract][Full Text] [Related]
30. Alterations in the relative abundance of the vasoactive intestinal peptide receptors (VPAC1 and VPAC2) and functions in uterine contractility during inflammation. Palus K; Całka J; Jana B Anim Reprod Sci; 2021 Feb; 225():106680. PubMed ID: 33388613 [TBL] [Abstract][Full Text] [Related]
31. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation. St Hilaire RC; Murthy SN; Kadowitz PJ; Jeter JR Peptides; 2010 Aug; 31(8):1517-22. PubMed ID: 20452385 [TBL] [Abstract][Full Text] [Related]
32. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis. Sun W; Hong J; Zang YC; Liu X; Zhang JZ Int Immunol; 2006 Dec; 18(12):1691-700. PubMed ID: 17077178 [TBL] [Abstract][Full Text] [Related]
33. Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis. Kim DH; Park IH; Cho JS; Lee YM; Choi H; Lee HM Am J Rhinol Allergy; 2011; 25(1):e44-7. PubMed ID: 21711977 [TBL] [Abstract][Full Text] [Related]
34. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
36. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors. Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659 [TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses. Wang Y; Mei Y; Bao S; Xu L Clin Exp Immunol; 2007 Apr; 148(1):178-87. PubMed ID: 17349016 [TBL] [Abstract][Full Text] [Related]
38. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855 [TBL] [Abstract][Full Text] [Related]
39. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Ito T Clin Dev Immunol; 2013; 2013():348546. PubMed ID: 24151515 [TBL] [Abstract][Full Text] [Related]
40. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. Shi H; Carion TW; Jiang Y; Steinle JJ; Berger EA Prostaglandins Other Lipid Mediat; 2016 Mar; 123():28-32. PubMed ID: 27026343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]